
Enzymes: Still cool after all these years
The first enzyme was discovered in 1833, almost 200 years ago and long before the nature of proteins was appreciated. The field of enzymology came into its own in the 20th century. Technological advances in the hands of creative enzymologists led to an ever-growing understanding of how enzymes achieve enormous rate accelerations as well as the structural basis for substrate specificity and allosteric regulation.
Submit an abstract
Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30.
Enzymologists continue to break new ground as we enter the 21st century. Our session at Discover BMB will feature new work on enzyme functions, mechanisms and applications.
Our first group of speakers will focus on enzymes that deal with problems caused by misbehaving metabolites. They will describe how enzymes can protect unstable intermediates and repair damaged metabolites. Our second group will explore the potential of using enzymes for biodegradation and green biosynthesis of chemicals currently produced from petrochemicals. Our final group will focus on enzymes that catalyze novel reactions, pushing the boundaries of chemistry accessible through biocatalysts.
Keywords: Substrate channeling, metabolite repair, biodegradation, green chemistry, natural product biosynthesis, radical chemistry.
Who should attend: Anyone who appreciates the awesome power of enzyme catalysis.
Theme song: by Paul Simon, because enzymes are crazy-efficient catalysts
This session is powered by the ribosome, which produces the enzymes that make life possible.
Cool and novel enzymes
Enzymatic control of problematic intermediates
Chair: Hung-Wen (Ben) Liu

Shelley D. Copley, University of Colorado Boulder
Tom Niehaus, University of Minnesota, Twin Cities
Shelley Minteer, University of Utah
Carole Linster, University of Luxembourg
Enzymes for a sustainable future
Chair: Shelley D. Copley
Gregg Beckham, National Renewable Energy Laboratory
Larry Wackett, University of Minnesota
Michelle Chang, University of California, Berkeley
Raquel Lieberman, Georgia Institute of Technology
New and unusual enzymatic transformations
Chair: Michelle Chang
Hung-wen (Ben) Liu, University of Texas at Austin
Aimin Liu, University of Texas at San Antonio
Sara O'Connor, Max Planck Institute for Chemical Ecology
Wenjun Zhang, University of California, Berkeley
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.

Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.

How HCMV hijacks host cells — and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.

Understanding the lipid link to gene expression in the nucleus
Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.

Receptor antagonist reduces age-related bone loss in mice
Receptor antagonist reduces bone loss and promotes osteoblast activity in aging mice, highlighting its potential to treat osteoporosis. Read more about this recent JBC paper.

Engineered fusion protein targets kiwifruit pathogen
Synthetic protein selectively kills kiwifruit pathogen, offering a promising biocontrol strategy for agriculture. Read more about this recent JBC paper.